Ivan Peyron

6PUBLICATIONS
19CO-AUTHORS
BiomaterialsMedical molecular engineering of nucleic acids and proteinsCardiology (incl. cardiovascular diseases)Proteins and peptidesHumoural immunology and immunochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2025
A bispecific nanobody for the treatment of von Willebrand disease type 1.

Ivan Peyron, Caterina Casari, Geneviève McCluskey

|Dec 23, 2022
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.

Claire Kizlik-Masson, Ivan Peyron, Stéphane Gangnard

|Jun 23, 2022
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.

Marie-Daniéla Dubois, Ivan Peyron, Olivier-Nicolas Pierre-Louis

|Apr 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein S.

Josepha C Sedzro, Frédéric Adam, Claire Auditeau

|Nov 02, 2020
Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications.

Ivan Peyron, Claire Kizlik-Masson, Marie-Daniéla Dubois

|Apr 13, 2016
Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.

Ankit Mahendra, Ivan Peyron, Olivier Thaunat

Pageof 1